Hosted on MSN11mon
Quest Diagnostics (DGX) Hurt by Lower Testing Sales, CompetitionQuest Diagnostics DGX is challenged by declining COVID-19 testing revenues ... In 2024, Quest Diagnostics is set to launch its first MRD test following the acquisition of Haystack Oncology.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback